Michael Hoffman - Onconova Therapeutics Insider

Onconova Therapeutics Inc -- USA Stock  

USD 0.93  0.0774  7.66%

Chairman of the Board

Mr. Michael B. Hoffman serves as Chairman of the Board of Onconova Therapeutics, Inc., since 2006. He is a member of the board of directors since December 2002. Since 2003, Mr. Hoffman was a managing director of Riverstone Holdings LLC, or Riverstone, where he is principally responsible for investments in power and renewable energy. Before joining Riverstone, Mr. Hoffman was senior managing director and head of the mergers and acquisitions advisory business of The Blackstone Group L.P., or Blackstone, where he also served on the firm principal group investment committee as well as its executive committee. Prior to joining Blackstone, Mr. Hoffman was managing director and cohead of the mergers and acquisitions department at Smith Barney, Harris Upham Co
Age: 65  Chairman Since 2006  MBA    
267-759-3680  http://www.onconova.com
Hoffman received his Bachelor and Master Degrees from Northwestern University and his M.B.A. from the Harvard Business School.

Michael Hoffman Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of (114.03) % which means that it has lost $114.03 on every $100 spent on asset. This is way below average.

Similar Executives

Entity Summary

Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule drug candidates to treat cancer. Onconova Therapeutics, Inc. was founded in 1998 and is headquartered in Newtown, Pennsylvania. Onconova Therapeutics is traded on Nasdaq Capital Markets in USA.Onconova Therapeutics Inc (ONTX) is traded on Nasdaq Capital Markets in USA. It is located in PENNSYLVANIA, U.S.A and employs 23 people. Onconova Therapeutics is listed under Pharmaceutical Products category by Fama And French industry classification.

Did you try this?

Run Focused Opportunities Now

Focused Opportunities

Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Hide  View All  NextLaunch Focused Opportunities

Fix Portfolio

Optimize Your Risk-Return Tradeoff
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Onconova Therapeutics Inc to your portfolio

Top Management

Onconova Therapeutics Inc Leadership Team
Henry Bienen, Director
Ramesh Kumar, CEO, Ph.D
Anne VanLent, Director
Ajay Bansal, CFO, MBA
Premkumar Reddy, Director, Ph.D
Jerome Groopman, Director
James Marino, Director
Manoj Maniar, SVP, MBA
Thomas McKearn, President
Michael Hoffman, Chairman, MBA
Jack Stover, Director
Steven Fruchtman, President
Mark Guerin, VP
Viren Mehta, Director, MBA

Stock Performance

Onconova Therapeutics Performance Indicators